Bergal H, Kinoshita K, Wong W
bioRxiv. 2025; .
PMID: 40060606
PMC: 11888394.
DOI: 10.1101/2025.02.27.640408.
Hamidinia M, Gu Y, Ser Z, Brzostek J, Tay N, Yap J
Cell Mol Life Sci. 2025; 82(1):94.
PMID: 40009199
PMC: 11865395.
DOI: 10.1007/s00018-025-05614-y.
Kubelick K, Kim J, Kim M, Huang X, Wang C, Song S
ACS Nano. 2025; 19(6):6079-6094.
PMID: 39908484
PMC: 11841050.
DOI: 10.1021/acsnano.4c12929.
Song X, Jiao J, Qin J, Zhang W, Qin W, Ma S
Front Immunol. 2025; 15():1494025.
PMID: 39840068
PMC: 11747552.
DOI: 10.3389/fimmu.2024.1494025.
Samarakoon Y, Yelland T, Garcia-Gonzalez E, da Silva Justo Junior A, Mahmood M, Manoharan A
Life Sci Alliance. 2025; 8(3).
PMID: 39814552
PMC: 11735834.
DOI: 10.26508/lsa.202403066.
Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cells.
Gad A, Morris J, Godret-Miertschin L, Montalvo M, Kerr S, Berger H
Sci Adv. 2025; 11(2):eadq8114.
PMID: 39792660
PMC: 11721525.
DOI: 10.1126/sciadv.adq8114.
Revealing the heterogeneity of treatment resistance in less-defined subtype diffuse large B cell lymphoma patients by integrating programmed cell death patterns and liquid biopsy.
Hua W, Liu J, Li Y, Yin H, Shen H, Wu J
Clin Transl Med. 2024; 15(1):e70150.
PMID: 39731274
PMC: 11680560.
DOI: 10.1002/ctm2.70150.
Diffusion-limited cytokine signaling in T cell populations.
Brunner P, Kiwitz L, Li L, Thurley K
iScience. 2024; 27(6):110134.
PMID: 39678490
PMC: 11639737.
DOI: 10.1016/j.isci.2024.110134.
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.
Melero I, de Miguel Luken M, de Velasco G, Garralda E, Martin-Liberal J, Joerger M
Nature. 2024; 637(8048):1218-1227.
PMID: 39663448
PMC: 11779642.
DOI: 10.1038/s41586-024-08305-z.
Underappreciated layers of antibody-mediated immune synapse architecture and dynamics.
Goldberg B, Ackerman M
mBio. 2024; 16(1):e0190024.
PMID: 39660921
PMC: 11708040.
DOI: 10.1128/mbio.01900-24.
Harnessing extracellular vesicle-mediated crosstalk between T cells and cancer cells for therapeutic applications.
Budayr O, Miller B, Nguyen J
J Control Release. 2024; 378:266-280.
PMID: 39657892
PMC: 11830559.
DOI: 10.1016/j.jconrel.2024.12.011.
Subverting to Prevent : Alteration of Effector Immune Cell Migration and Adhesion as a Key Mechanism of Tumor Immune Evasion.
Mastrogiovanni M, Donnadieu E, Pathak R, Di Bartolo V
Biology (Basel). 2024; 13(11).
PMID: 39596815
PMC: 11591779.
DOI: 10.3390/biology13110860.
Comparative Analysis of Bispecific Antibodies and CAR T-Cell Therapy in Follicular Lymphoma.
Morabito F, Martino E, Nizzoli M, Talami A, Pozzi S, Martino M
Eur J Haematol. 2024; 114(1):4-16.
PMID: 39462177
PMC: 11613673.
DOI: 10.1111/ejh.14335.
Mechanism of Action and Pharmacokinetics of Approved Bispecific Antibodies.
Choi S, Lee J, Ko S, Hong S, Jin H
Biomol Ther (Seoul). 2024; 32(6):708-722.
PMID: 39448393
PMC: 11535297.
DOI: 10.4062/biomolther.2024.146.
A novel method for characterizing cell-cell interactions at single-cell resolution reveals unique signatures in blood T cell-monocyte complexes during infection.
Kang N, Chawla A, Hillman H, Tippalagama R, Kim C, Mikulski Z
bioRxiv. 2024; .
PMID: 39386643
PMC: 11463634.
DOI: 10.1101/2024.09.20.612103.
Mechanisms and therapeutic potential of disulphidptosis in cancer.
Li Y, Zhang H, Yang F, Zhu D, Chen S, Wang Z
Cell Prolif. 2024; 58(1):e13752.
PMID: 39354653
PMC: 11693557.
DOI: 10.1111/cpr.13752.
Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2.
Jo Y, Sim H, Yun B, Park Y, Jin H
Exp Mol Med. 2024; 56(10):2113-2126.
PMID: 39349829
PMC: 11541569.
DOI: 10.1038/s12276-024-01317-9.
VISION - an open-source software for automated multi-dimensional image analysis of cellular biophysics.
Weber F, Iskrak S, Ragaller F, Schlegel J, Plochberger B, Sezgin E
J Cell Sci. 2024; 137(20).
PMID: 39258319
PMC: 11529879.
DOI: 10.1242/jcs.262166.
Cytosolic protein translation regulates cell asymmetry and function in early TCR activation of human CD8 T lymphocytes.
Gomez-Moron A, Tsukalov I, Scagnetti C, Pertusa C, Lozano-Prieto M, Martinez-Fleta P
Front Immunol. 2024; 15:1411957.
PMID: 39114656
PMC: 11303187.
DOI: 10.3389/fimmu.2024.1411957.
Mathematical models of TCR initial triggering.
Shi J, Yin W, Chen W
Front Immunol. 2024; 15:1411614.
PMID: 39091495
PMC: 11291225.
DOI: 10.3389/fimmu.2024.1411614.